Olin Corporation (NYSE: OLN) — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; comparisons are with Q1 2023 unless otherwise noted. Amounts are in U.S. dollars, in millions except per-share data. Olin manufactures chemicals and ammunition through Chlor Alkali Products and Vinyls, Epoxy, and Winchester.
Financial performance
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Sales | $1,635.3 | $1,844.3 |
| Gross margin | $207.3; 13% of sales | $402.6; 22% of sales |
| Operating income | $97.3 | $230.4 |
| Net income attributable to Olin | $48.6 | $156.3 |
| Diluted earnings per share | $0.40 | $1.16 |
| Cash provided by operating activities | $81.0 | $37.5 |
| Capital expenditures | $44.3 | $61.4 |
Sales declined 11%, and Olin-attributable net income fell 69%. Management attributed the earnings decline mainly to weaker results in the two chemicals segments, partly offset by Winchester. Interest expense was $44.6, versus $42.4; the income tax provision was $12.5, versus $40.8. Restructuring charges were $8.3, down from $60.9, including $57.8 of Epoxy Optimization Plan charges in Q1 2023.
Segment results and material changes
- Chlor Alkali Products and Vinyls: Sales were $884.6, down 21%; segment income was $76.6, versus $245.9. Lower caustic soda pricing and lower volumes were the primary pressures.
- Epoxy: Sales were $341.3, down 5%; the segment recorded a loss of $11.8, versus income of $21.4. Lower prices, amid substantial Asian exports into European and North American markets, outweighed higher volumes.
- Winchester: Sales were $409.4, up 12%; segment income increased to $72.2 from $61.0. Higher commercial ammunition volumes, including White Flyer sales, supported results; lower pricing partly offset the gains.
Cash, debt, and liquidity
Cash and cash equivalents were $150.9 at March 31, 2024, down from $170.3 at year-end 2023. Total long-term borrowings, including current installments, were $2,765.7; $988.4 was variable-rate debt. Olin reported $1,038.6 available under its $1.2 billion revolving credit facility and no additional borrowing capacity under its receivables financing agreement, which was constrained by its borrowing base. The company said it was compliant with debt covenants and believed available liquidity was sufficient for operating, debt-service, and capital needs. Debt to total capitalization was 55.6%, compared with 54.1% at December 31, 2023.
Q1 net debt borrowings were $94.7. Olin repurchased 2.0 million shares for $105.4 and paid $23.9 in dividends; the quarterly dividend was $0.20 per share. Working capital increased $89.0, less than the $244.4 increase in Q1 2023, helping operating cash flow rise despite lower operating results. The $425.0 million receivables financing agreement had $332.4 drawn.
Outlook, risks, and contingencies
- Management reported sequential improvement in all three segments in Q1 and expected that momentum to continue. It forecast Q2 2024 operating results above Q1 overall, with chemical-segment results higher and Winchester results comparable to Q1.
- For 2024, Olin expected capital spending of $225–$250, approximately $50 of payments under long-term supply contracts for Gulf Coast energy modernization, and depreciation and amortization of $500–$525. It projected an effective tax rate of 25%–30% and a cash tax rate of 35%–40%.
- Expected 2024 environmental expense was $25–$35, compared with $23.7 in 2023; environmental spending was estimated at approximately $30. Environmental reserves were $154.8 at quarter-end. Management cautioned that environmental outcomes and costs are uncertain and could materially affect results or financial position.
- Olin expected approximately $20 of additional charges through 2025 for the Epoxy Optimization Plan and approximately $45 through 2027 for other restructuring plans. The remaining accrued restructuring balance was $17.5.
- Olin filed U.S. antidumping and countervailing duty petitions in April 2024 concerning epoxy resins imported from China, India, South Korea, Taiwan, and Thailand. The filing identifies market demand and pricing, manufacturing disruptions, input costs, debt and covenant capacity, environmental obligations, litigation, regulation, and government-contract performance as risks.
- Accrued liabilities for other legal actions, including asbestos-related proceedings, were $17.7. Olin said it did not believe these actions were reasonably likely to materially adversely affect its financial position, cash flows, or results; outcomes remain subject to uncertainty.
Important facts for investors to verify
- Whether chemical pricing, especially caustic soda and epoxy resin prices, and segment volumes recover as management expects.
- Whether Q2 improvement and the stated 2024 tax, capital-spending, and environmental-cost outlook remain achievable.
- Debt levels, variable-rate exposure, covenant headroom, and availability under the revolving and receivables financing facilities.
- The cash-flow and balance-sheet effects of continued share repurchases, dividends, and environmental and restructuring spending.
- Developments and potential costs related to environmental matters, legal proceedings, and the epoxy trade petitions.